Results 41 to 50 of about 1,370,177 (306)

Generalised anxiety disorder doubles risk of cardiovascular events in people with stable coronary heart disease [PDF]

, 2011
Does generalised anxiety disorder (GAD) affect cardiovascular events associated with coronary heart disease (CHD)? Population: 1015 patients with stable coronary heart. Eligible patients had at least one of the following: history of myocardial infarction
Phillips, Anna C.
core   +1 more source

Neck circumference and waist circumference associated with cardiovascular events in type 2 diabetes (Beijing Community Diabetes Study 23)

Scientific Reports, 2021
Obesity increases the risk of developing cardiovascular disease and other metabolic diseases. We intended to compare three different anthropometric indicators of obesity, in predicting the incidence of cardiovascular events in Chinese type 2 diabetes ...
Guang-Ran Yang, Ming-Xia Yuan, Gang Wan, Xue-Lian Zhang, Han-Jing Fu, Shen-Yuan Yuan, Liang-Xiang Zhu, Rong-Rong Xie, Jian-Dong Zhang, Yu-Ling Li, Yan-Hua Sun, Qin-Fang Dai, Da-Yong Gao, Xue-Li Cui, Jian-Qin Gao, Zi-Ming Wang, Ying-Jun Chen, Yong-Jin Li, Dong-Ming Hu, Juan Gao, Ying Gao, Jie Miao, Yu-Jie Chen, Rury. R. Holman   +23 more
doaj   +1 more source

Cardiovascular events more than 6 months after pregnancy in patients with congenital heart disease

Open Heart, 2023
Objectives Patients with congenital heart disease (CHD) are increasingly pursuing pregnancy, highlighting the need for data on late cardiovascular events (more than 6 months after delivery).
Ian S Harris, Juan Gonzalez, Nisha Parikh, Anushree Agarwal, Vidhushei Yogeswaran, Sarah Blissett, Hayley Schultz, Nasim C Sobhani, Jessica Hong   +8 more
doaj   +1 more source

Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease : a prospective cohort study [PDF]

, 2015
Background : Soluble tumor necrosis factor receptors 1 (sTNFR1) and 2 (sTNFR2) have been associated to progression of renal failure, end stage renal disease and mortality in early stages of chronic kidney disease (CKD), mostly in the context of diabetic ...
AS Levey, C Obregon, CL Meuwese, D Aderka, D Aderka, DE Weiner, DV Barreto, EL Knight, Eva Schepers, FI Hawari, Francis Verbeke, G Tripepi, Griet Glorieux, JF Leeuwenberg, JK Pinckard, JM Luna, KJ Van Zee, L Cabal-Hierro, L Nilsson, Leighton R James, M Goicoechea, M Tonelli, M Valgimigli, MA Niewczas, MG Shlipak, MHA Bemelmans, Nathalie Neirynck, PJ Saulnier, Raymond Vanholder, RB Schnabel, S Soriano, S Xanthoulea, SJ Levine, T Gohda, T Kohno, T Ueland, V Panichi   +36 more
core   +7 more sources

Long-term risk and predictors of cerebrovascular events following sepsis hospitalization: A systematic review and meta-analysis

Frontiers in Medicine, 2022
BackgroundLong-term risk and predictors of cerebrovascular events following sepsis hospitalization have not been clearly elucidated. We aim to determine the association between surviving sepsis hospitalization and cerebrovascular complications in adult ...
Amanuel Godana Arero, Amanuel Godana Arero, Ali Vasheghani-Farahani, Ali Vasheghani-Farahani, Bereket Molla Tigabu, Godana Arero, Beniyam Yimam Ayene, Danesh Soltani, Danesh Soltani   +8 more
doaj   +1 more source

BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD. [PDF]

, 2018
BACKGROUND AND OBJECTIVES: In the Systolic Blood Pressure Intervention Trial (SPRINT), intensive systolic BP treatment (target
Dias, C, Leitão, L, Magriço, R, Neves, J, Vieira, M   +4 more
core   +1 more source

Cardiovascular adverse events of ibrutinib [PDF]

Blood, 2019
In this issue of Blood, Dickerson et al report on the increased incidence and worsening severity of hypertension and its association with cardiovascular outcomes in 562 patients treated with ibrutinib for B-cell malignancies.
openaire   +2 more sources

Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa, Daisuke Honda, Seigo Akari, Tadao Akizawa   +3 more
wiley   +1 more source

Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice [PDF]

, 2016
Diabetic patients suffer from a high rate of cardiovascular events and such risk increases with HbA1c. However, lowering HbA1c does not appear to yield the same benefit on macrovascular endpoints, as observed for microvascular endpoints. As the number of
Avogaro, Angelo, Bonora, Enzo, Fadini, GIAN PAOLO, Prato, Stefano Del, Sesti, Giorgio   +4 more
core   +3 more sources

Cardiovascular Events after AKI [PDF]

Journal of the American Society of Nephrology, 2014
The possibility that AKI is a risk factor for subsequent cardiovascular disease is an intriguing one. Several studies have shown that survivors of AKI are at increased risk of death and CKD. Because cardiovascular disease is the leading cause of death in many countries, it would be useful to understand whether there is increased risk of cardiovascular ...
Chi-Yuan, Hsu, Kathleen D, Liu
openaire   +2 more sources